somatotroph is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
Binding of tesamorelin to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and the release of growth hormone into circulation. Because the peptide acts upstream of the growth hormone axis, its effects are partly mediated by hepatic insulin-like growth factor 1 (IGF-1) production. The pulsatile character of endogenous growth hormone secretion is preserved rather than replaced. Whether amplified signaling produces effects beyond those of native GHRH remains an area of ongoing investigation.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
The basis of Dr. Quimby's theory is that there is no intelligence, no power or action in matter of itself, that the spiritual world to which our eyes are closed by ignorance or unbelief is the real world, that in it lie all the causes for every effect visible in the natural world, and that if this spiritual life can be revealed to us, in other words if we can understand ourselves, we shall then have our happiness or misery in our own hands ..." By 1856, Quimby had 500 patients a year. He would sit next to them and explain that the disease was something their minds could control; sometimes he would wet his hands and rub their heads, but it was the talking that helped them, he said, not the manipulation. Quimby began to write his thoughts down around 1859—his work was published posthumously as The Quimby Manuscripts in 1921—and was generous in allowing his patients to copy one of his essays, "Questions and Answers." This became an issue, from 1883 onwards, when Eddy was accused of having based Christian Science on his work.
== Clinical significance == Clinical attachment loss is one of the three characteristic factors of periodontitis. In clinical practice, CAL is the primary feature assessed to diagnose periodontitis. Periodontitis is diagnosed when
=== Provincial government === Yasir Naqvi, the Attorney General of Ontario, and Eric Hoskins, the province's Minister of Health and Long-Term Care, jointly announced on the day of Wettlaufer's sentencing that the provincial government would commission a public inquiry into her case. The full details of the inquiry were not given in the announcement, as the government had yet to determine the scope or an individual to lead the inquiry, with Naqvi and Hoskins instead saying that the inquiry would "get the answers we need to help ensure a tragedy such as this does not happen again." The delay in establishing the inquiry was criticized by members of the opposition Progressive Conservative and New Democratic parties toward the end of July 2017, as no progress had seemingly been made since the announcement and the Legislative Assembly had risen for its summer recess. The Public Inquiry into the Safety and Security of Residents in the Long-Term Care Homes System was formally established by the provincial government on August 1, 2017. Justice Eileen Gillese of the Court of Appeal for Ontario was appointed commissioner of the inquiry. The inquiry was to include interviews with victims' families and public consultations in the community as it investigated the circumstances surrounding the deaths of Wettlaufer's victims and gaps in legislative or policy frameworks that allowed her to continue working as a nurse. The inquiry's lead counsel stated that "anyone from Wettlaufer to Premier Kathleen Wynne" may be called to testify before the inquiry based on the evidence that is uncovered.
== Directors == Lenton Parr, 1972–1984 (Victorian College of the Arts proclaimed 30 November 1972) Lionel Lawrence, 1985–1988 Alwynne Mackie, 1989–1995 Andrea Hull, 1995–2009 Su Baker, 2010–2017 Jon Cattapan, 2017–2020 Barbara Bolt, 2020–2021 Emma Redding, 2022–present
Sources: en.wikipedia.org
Potential protective or attenuating agents include GnRH analogs, where several studies have shown a protective effect in vivo in humans, but some studies show no such effect. Sphingosine-1-phosphate (S1P) has shown similar effect, but its mechanism of inhibiting the sphingomyelin apoptotic pathway may also interfere with the apoptosis action of chemotherapy drugs. In chemotherapy as a conditioning regimen in hematopoietic stem cell transplantation, a study of people conditioned with cyclophosphamide alone for severe aplastic anemia came to the result that ovarian recovery occurred in all women younger than 26 years at time of transplantation, but only in five of 16 women older than 26 years.
Aside from individual reported experiences, there has been a limited amount of published work summarizing salvia divinorum's effects. A survey of salvia users found that 38% described the effects as unique in comparison to other methods of altering consciousness. 23% said the effects were like yoga, meditation, or trance. Users have written prose about their experiences; some describing their visions pictorially, and there exist examples of 'salvia-inspired' visionary art. Others claim musical inspiration from the plant.
For many years, controversy has surrounded the use of involuntary treatment and use of the term "lack of insight" in describing patients. Internationally, mental health laws vary significantly but in many cases, involuntary psychiatric treatment is permitted when there is deemed to be a significant risk to the patient or others due to the patient's illness. Involuntary treatment refers to treatment that occurs based on a treating physician's recommendations, without requiring consent from the patient. Inpatient psychiatric wards may be secure (for those thought to have a particular risk of violence or self-harm) or unlocked/open. Some wards are mixed-sex whilst same-sex wards are increasingly favored to protect women inpatients. Once in the care of a hospital, people are assessed, monitored, and often given medication and care from a multidisciplinary team, which may include physicians, pharmacists, psychiatric nurse practitioners, psychiatric nurses, clinical psychologists, psychotherapists, psychiatric social workers, occupational therapists and social workers. If a person receiving treatment in a psychiatric hospital is assessed as at particular risk of harming themselves or others, they may be put on constant or intermittent one-to-one supervision and may be put in physical restraints or medicated. People on inpatient wards may be allowed leave for periods of time, either accompanied or on their own. In many developed countries there has been a massive reduction in psychiatric beds since the mid 20th century, with the growth of community care.
However, the Smith government still professed loyalty to Elizabeth II, and accordingly the document reconstituted Rhodesia as a Commonwealth realm with Elizabeth as "Queen of Rhodesia". The new constitution created the concept of allegiance to the "Constitution of Rhodesia", and introduced the post of Officer Administering the Government, a viceregal figure empowered to sign passed legislation into law on behalf of the monarch if she did not appoint a Governor-General. The Rhodesian Cabinet waited in vain for Wilson's reply for the rest of 9 November and the next day. After briefly meeting Smith late on 10 November, Johnston warned Wilson that evening that the Rhodesians seemed poised to declare independence in the morning. The British prime minister tried repeatedly to call Smith, but did not get through until Smith was already chairing a Cabinet meeting on the independence issue around 08:00 Central Africa Time (06:00 in London) on 11 November. Wilson attempted to talk Smith out of unilateral action by telling him the status quo could continue, and the two argued inconclusively about the proposed Royal Commission. Returning to his Cabinet meeting, Smith reported the conversation to his ministers, and, after debating for a while, the Cabinet came to the conclusion that Wilson was simply attempting to buy more time and that there was no sign of actual progress. Smith asked if Rhodesia should declare its independence, and had each Cabinet minister answer in turn.
Activation-induced death of primary T lymphocytes and other important constituents of the immune response are caspase-independent and necrotic by morphology; hence, current researchers have demonstrated that necrotic cell death can occur not only during pathological processes, but also during normal processes such as tissue renewal, embryogenesis, and immune response.
Sources: en.wikipedia.org
=== Metabolic syndrome === Multiple cross-sectional studies have found associations between early androgenic alopecia, insulin resistance, and metabolic syndrome, with low HDL being the component of metabolic syndrome with highest association. Linolenic and linoleic acids are 5 alpha reductase inhibitors. Premature androgenic alopecia and insulin resistance may be a clinical constellation that represents the male homologue, or phenotype, of polyendocrine metabolic ovarian. Others have found a higher rate of hyperinsulinemia in family members of women with polyendocrine metabolic ovarian. With early-onset androgenetic alopecia having an increased risk of metabolic syndrome, poorer metabolic profiles are noticed, including metrics for body mass index, waist circumference, fasting glucose, blood lipids, and blood pressure. In support of the association, finasteride improves glucose metabolism and decreases glycated hemoglobin HbA1c, a surrogate marker for diabetes mellitus. The low SHBG seen with premature androgenic alopecia is also associated with, and likely contributory to, insulin resistance, and for which it still is used as an assay for pediatric diabetes mellitus. Obesity leads to upregulation of insulin production and a decrease in SHBG. Further reinforcing the relationship, SHBG is downregulated by insulin in vitro, although SHBG levels do not appear to affect insulin production. In vivo, insulin stimulates both testosterone production and SHBG inhibition in normal and obese men.
However, Oscar Tiegs' involvement in imparting knowledge started much earlier than his time at the University of Melbourne, he being a student demonstrator in biology at the University of Queensland in 1918.
== Diagnosis == In addition to hematoxylin-eosin staining to evaluate histological changes, lesion characteristics, genetic history, and special histochemical staining to highlight the composition of connective tissue nevus for differentiation, these tests are necessary for the diagnosis of connective tissue nevus.
On February 26, the FDA warned a California manufacturer of a kratom product called "Mitrasafe" that the supplement was not confirmed as safe, was not approved as a dietary supplement or drug, and was illegal for interstate commerce. Although it was a federally legal dietary supplement, kratom was not approved as a therapeutic agent in the United States due to the poor quality of the research. In November 2017, the FDA cited serious concerns over the marketing and effects (including death) associated with the use of kratom in the United States, stating that "There is no reliable evidence to support the use of kratom as a treatment for opioid use disorder; there are currently no FDA-approved therapeutic uses of kratom... and the FDA has evidence to show that there are significant safety issues associated with its use."
=== „Sozusagen Paris“ (2016) === „Sozusagen Paris“' (Paris, So to Speak) constitutes a sequel to the previous novel: after a public reading from „Love Writ Large“, the first-person narrator is approached by his childhood sweetheart, who is now the mayor of a small town. This sequel describes the first encounter between the two characters after thirty years, which lasts from the moment of their reunion after the public reading until the next morning. Overall, the text complements its predecessor: whereas the former dealt with the ecstasy of first love, the latter focuses on long-term love, specifically in light of Jutta's 23-year marriage. Whereas „Love Writ Large“ was told from the man's perspective, the nighttime conversation in Paris, So to Speak is shaped by the woman’s point of view —for the first time in Kermani's work, a female voice is at the center of the text. Like „Love Writ Large, Paris So to Speak“ also aims at a supra-individual exploration of love, but it is anchored differently: instead of early Islamic mysticism, it’s the French marriage novels of the nineteenth century up to Marcel Proust which serve as a foil here for modern love. This shifts the reflection on love from a general anthropological to a historical perspective. In particular, the important role of their children to the couple's life, lifestyle, and emotional stability serves to emphasize distinctions from older marriage novels and to highlight specifics of love and cohabitation in the 21st century.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
It mirrors the 44-residue form of human growth hormone-releasing hormone. A hexenoyl group on the N-terminal tyrosine distinguishes it from the unmodified hormone. The change is intended to improve resistance to enzymatic breakdown.